NRG ENERGY, INC. - COMMON STOCK (NRG)

CUSIP: 629377508

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
+1,212,187
Put/Call ratio
88%
SEC-reported price per share
$159.24
Indexed holders
1,062
Value change
+$185,994,817
Number of buys
509
Open additional details 1 more signal available
Number of sells
491
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
212,072,138

Security key

629377508

Report period

Q4 2025

Indexed institutions

1,062

Top holders

10

Ownership snapshot

Top reported holders of NRG - NRG ENERGY, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
2/15
Latest evidence
30 Sep 2025
13F 13D/G Lead comparable stake: 7.7% 13 rows are not safely comparable across share classes. 13D/G row: BlackRock, Inc. Showing 1-6 of 15 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 7.7%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership Top 2
BlackRock, Inc. 7.7%
GOLDMAN SACHS GROUP INC 3.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13F 13D/G
Company
7.7%
Reported 13D/G · 31 Mar 2025
$2,879,420,839
17,779,691 shares
— 30 Sep 2025
GOLDMAN SACHS GROUP INC
13D/G 13F
THE GOLDMAN SACHS GROUP, INC. · Company
3.1%
Reported 13D/G · 30 Jun 2025
$959,250,739
6,044,809 shares
-$695,481,618 30 Jun 2025
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$4,080,604,430
25,196,693 shares
— 30 Sep 2025
FMR LLC
13F
Company
13F
—
denominator unverified
$2,377,625,506
14,681,232 shares
— 30 Sep 2025
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$1,722,134,517
10,633,742 shares
— 30 Sep 2025
FRANKLIN TEMPLETON INC
13F
Company
13F
—
denominator unverified
$1,274,668,936
7,870,756 shares
— 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
1,062
Shares
178,706,218
Indexed holders
1,062
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 indexed holders
1,039
Q4 2025 indexed holders
1,062
Indexed holder difference
23
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .